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Introduction.Thisstudyevaluatestheprogressionofdementiaandidentiﬁesprognosticriskfactorsfordementia.Methods.Agroup
of 80 Brazilian community residents with dementia (34 with Alzheimer’s disease and 46 with vascular dementia) was assessed over
the course of 2 years. Data were analyzed with Cox regression survival analysis. Results. The data showed that education predicted
cognitive decline (HR = 1.2; P<. 05) when analyzed without controlling for vascular risk factors. After the inclusion of vascular
risk factors, education (HR = 1.32; P<. 05) and hypertension were predictive for cognitive decline (HR = 38; P<. 05), and
Alzheimer’s disease diagnosis was borderline predictive (P = .055). Conclusion. Vascular risk factors interacted with the diagnosis
of vascular dementia. Education was a strong predictor of decline.
1.Introduction
It is estimated that 24.3 million people suﬀer from dementia
today, with 4.6 million new cases every year. Of those with
dementia, 60% live in developing countries, and the rate of
increase in prevalence is predicted to be three to four times
higher in developing countries than in developed countries
[1].
In most prevalence studies, Alzheimer’s disease (AD) has
been associated with 70% or more of all cases of dementia
andthemaincontributortothesteepincreasewithageinthe
prevalenceofdementia[2].Inturn,dementiawithavascular
component comprises nearly half of all cases of dementia in
persons aged 85 years and older [3]. Patients with vascular
dementia (VaD) have poorer survival than those with AD:
themediansurvivalfromdementiaonsettodeathis3.9years
for patients with vascular dementia (VaD) and 7.1 years for
patients with AD [4].
It is important to evaluate the progression of dementia
andtoestimatepredictorsofcognitiveandfunctionaldecline
in patients with an established diagnosis of dementia. Gen-
der, education, and time from AD onset did not signiﬁcantly
predict cognitive and functional decline in one study [5].
In another study, there were also no predictors of disease
progression except for gender: men exhibited a greater
rate of cognitive decline than women [6]. Another report
demonstrated that, during the early and very late stages
of AD, cognitive deterioration was slower than during the
middle stages and no clinical variables other than the degree
of cognitive impairment and previous rate of cognitive
decline predicted deterioration [7].
Higher education and participation in prediagnostic
activitieshavebeenassociatedwithfastercognitivedeclinein
many AD longitudinal studies [8–10]. In addition, psychotic
symptoms and disruptive behavior predicted faster disease
progression in both the cognitive and functional dimensions2 International Journal of Alzheimer’s Disease
of AD [11]. Diﬀuse cognitive impairments predicted cog-
nitive decline, and visuospatial deﬁcits predicted functional
progression in AD [12].
Among patients with VaD, longitudinal changes in
instrumental and basic activities of daily living were most
strongly associated with changes in executive functioning
and memory abilities, respectively [13]. Independent of both
level and rate of change of prestroke cognitive performance
and other risk factors for cognitive decline, incident stroke
was associated with more than twice the risk of subsequent
dementia (hazard ratio, 2.1; 95% CI, 1.55 to 2.81). Among
those persons who developed dementia after stroke, 58.2%
were diagnosed with VaD, and 32.7% were diagnosed with
AD [14]. High cerebrovascular disease burden in VaD was
associated with the worst survival rate [15].
VaD and AD have been linked to a number of cardiovas-
cular factors [16–20], but the eﬀect of vascular risk factors
on the progression of already-established dementia has been
less studied. Vascular risk factors measured clinically and
biochemicallydidnotsigniﬁcantlyincreasetherateofdeteri-
oration during 18 months in AD patients with a low burden
of cerebrovascular risk factors; however, cerebrovascular
events predicted cognitive decline in AD [21]. Decreased
cardiovascularreactivity, atrialﬁbrillation, systolic hyperten-
sion, and angina also predicted faster decline in AD patients
[22, 23]. History of coronary artery bypass graft surgery,
diabetes, and treatment with antihypertensive medications
were associated with slower rate of decline [23]. On the
other hand, a longitudinal study did not ﬁnd an association
between baseline cardiovascular risk factors and progression
from CDR 1.0 to CDR 2.0 over an 18-month follow-up [24].
We hypothesized that VaD patients would present faster
decline than AD patients. We also hypothesized that younger
and more educated patients and those with higher exposure
to vascular risk factors would present faster decline. As
VaD patients presented with more vascular risk factors, we
supposed that this combination would also increase the rate
of progression of VaD.
The main objective of the present study was the evalua-
tion of the progression of dementia (the severity of decline)
in AD and VaD. Most patients were mildly to moderately
dementedatbaseline.Wealsoanalyzedpredictorsofprogres-
sion of severity of dementia.
2. Methods
Eighty AD and VaD patients were selected consecutively
from the Dementia Outpatient Clinic and enrolled in a
cohort study to evaluate the progression of dementia severity
and clinical predictors of decline. This sample size was
suﬃc i e n tt od e t e c t1 5 %d i ﬀerences in risk for decline
(P<. 05). The diagnosis of AD followed the criteria
of the NINCDS-ADRDA for probable AD. VaD was diag-
nosed by the National Institute of Neurological Disorders
and Stroke-Association Internationale pour la Recherche et
l’Enseignement en Neurosciences (NINDS-AIREN) criteria
[25]. The Hachinski Ischemic Score (HIS) [26] was also
applied in all patients to verify that an ischemic process was
associated with VaD and to exclude ischemia in AD.
The assessments were carried out every 6 months over
2 years. At the interviews, patients, corroborated by their
caregivers, were evaluated for cognition and behavior. The
following assessments were made at baseline. Demographic
data, including educational attainment and Portuguese ﬂu-
ency, were collected for all patients. The risk factors for
cerebrovascular disease, hypertension, and diabetes were
evaluated by clinical history and physical examination.
Hypertension was deﬁned as systolic blood pressure of
≥140mmHg, diastolic blood pressure of ≥90mmHg, or by
the use of prescribed antihypertensive medication. Diabetes
mellitus was considered present if the patient had a fasting
glucoselevelof≥120mg/dLorusedantidiabeticmedication.
Family history of dementia and neuroimaging ﬁndings were
also collected at study entry, and a neurological examination
was performed. A senior neuroradiologist, working with
dementia neuroimage for more than 5 years, blinded to
the clinical data, performed the readings of CT scans.
The analyses were qualitative. Atrophy was deﬁned sub-
jectively, based on telencephalic cortical sulci prominence
and lateral ventricles diameter. Leukoaraiosis was deﬁned as
bilateral and nearly symmetrical areas of decreased density
of the periventricular white matter and centrum semiovale.
Focal abnormality was described as areas of hypoden-
sity without leukoaraiosis, expressing ischemic lacunae, on
neuroimage.
Baseline severity of dementia was assessed with the
Clinical Dementia Rating (CDR) scale, applied by trained
interviewers [27, 28]. The CDR was considered a categorical
variable by coding mild, moderate and severe as 1, 2, and 3,
respectively.
The detailed examinations at each follow-up assessment
included medical, neurological, neuropsychiatric, and cogni-
tive evaluations, by three neurologists and one psychiatrist.
The CDR scale was also used at each follow-up assessment.
The main outcome assessed was the disease progression
in terms of dementia severity. The change from a milder
category on CDR to a severer condition on this scale (i.e.,
a one-point drop in CDR) was considered an indicator of the
progression of dementia severity. The study was approved by
the Ethics Committee for Medical Research at the University
Hospital where it took place. Informed consent was obtained
from the subjects or their nearest relatives or both.
3.StatisticalAnalyses
Progression of dementia severity was evaluated by Cox
regression survival analysis, and survival curves were derived
with the Kaplan-Meier’s method. The date of the follow-up
when a one-point drop in CDR was recorded marked the
occurrence of disease progression. The following variables
were considered as predictors of disease progression: age,
sex, education, diagnosis (AD or VaD), diabetes, hyperten-
sion, and neuroimaging ﬁndings at study entry. Two Cox
proportional hazards models were performed to determine
whether baseline variables could predict the progression of
dementia. In the ﬁrst model, age, sex, educational level,
familyhistoryofdementia,neuroimagingﬁndings,anddiag-
nosis (AD or VaD) were considered as explanatory variables.International Journal of Alzheimer’s Disease 3
In the second analysis, vascular risk factors were added as
an explanatory variable to the previously used factors in
the model.
All procedures were carried out with the Statistical
Package for the Social Sciences (SPSS) 14 for Windows.
4. Results
The sample of the ﬁrst evaluation (at entry to the study)
was composed of 80 patients: 39 (49%) males and 41 (51%)
females. The mean ± SD age at entry to the study was 69.9 ±
8.9 years (range: 50 to 87 years), and education level varied
from0to16yearsofschooling(4.57 ±4.02,mean ± SD).Of
the 80 patients in our ﬁrst analysis, 34 (43%) fulﬁlled criteria
forprobableAD,and46(57%)forprobableVaD.Allpatients
with VaD had a history of the previous stroke at baseline.
Of the 80 patients enrolled in the study, 28 did not present
any vascular risk factor. Hypertension was observed in 37
patients, diabetes in 6, and the association of hypertension
and diabetes in 9. AD patients at baseline were mild (CDR =
1) (n = 20), moderate (CDR = 2) (n = 9), and severe
(CDR = 3) (n = 5), and VaD patients were mild (CDR = 1)
(n = 27) and moderate (CDR = 2) (n = 19). The sample
included only community-dwelling patients (Table 1).
Progression of dementia severity during the 2-year
follow-up was observed in 17 patients. No improvements
wereobservedduringthefollow-up.StrokeoccurrenceinAD
patients or reoccurrence in VaD patients was not observed
during the 2-year follow-up.
In the ﬁrst multivariate Cox model without vascular risk
factors,educationwastheonlysigniﬁcantvariable(HR=1.2;
CI 95% 1.02–1.37; P = .024). One more year of education
increased the risk (hazard ratio) 1-2-fold (Table 2).
However, in the second multivariate Cox model with
the inclusion of vascular risk factors (hypertension, diabetes,
and hypertension + diabetes), education and hypertension
were signiﬁcant factors. Diagnosis (AD or VaD) was not
signiﬁcant in the ﬁrst model (P = .94), but showed a
borderline eﬀect in the second model (P = .055). For the
second model, one year more of education increased the
risk of dementia progression 1.32 times, and the presence of
hypertension increased the risk 38 times (Table 3).
Figures 1 and 2 display the rate of progression of AD
and VaD obtained from the two Cox regression models. In
Figure 1, the progression was similar between AD and VaD.
On the other hand, Figure 2 demonstrates slow progression
of VaD—almost 4/5 of the period of observation with
acceleration at the end of the period—and fast progression
of AD.
5. Discussion
This longitudinal study was designed to evaluate the rate of
progression and predictors of progression of dementia sever-
ity. The main ﬁndings of the present study were the similar
evolution of severity in both AD and VaD, and the impact
of hypertension on the progression of dementia. When the
course of VaD was analyzed without control for the vascular
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Figure 1: Survival Rate in Relation to Severity of Dementia (CDR
scale): without vascular risk factor in the model.
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Figure 2: Survival Rate in Relation to Severity of Dementia (CDR
scale): with vascular risk factor in the model.
risk factors, the progression was similar to that of AD. After
the addition of these factors—speciﬁcally hypertension—
to the model, VaD presented slower progression (P =
.055). Additionally, higher education was associated with
faster disease progression in dementia patients in both
mathematical models.4 International Journal of Alzheimer’s Disease
Table 1: Demographic and clinical data at study entry.
Variable Alzheimer (N = 34) Vascular (N = 46)
Age (in years) mean ± SD (range) 73.23 ± 7.72 (60–87) 67.41 ± 9.08 (50–86)
Sex
Male 11 (32%) 28 (61%)
Female 23 (68%) 18 (39%)
Educational Attainment (in years) mean ± SD (range) 4.30 ± 3.99 (0–16) 4.76 ± 4.06 (0–16)
Vascular risk factors
None 28 (82%) —
Hypertension 04 (12%) 33 (72%)
DM 02 (6%) 04 (9%)
Hypertension + DM 00 (0%) 09 (20%)
Family history
No 18 (53%) 24 (52%)
Yes 11 (32%) 08 (17%)
Uncertain 05 (15%) 14 (30%)
Duration of follow-up (in months) mean ± SD (range) 11.01 ± 6.19 (3–25) 11 ± 6.31 (3–27)
Neurological Examination
Normal 34 (100%)
Neurological sign (hemiparesis, lower facial
weakness, Babinski sign, sensory deﬁcit, — 25 (59%)
hemianopia, and dysarthria)∗
Other discrete symptoms- 19 (41%)
(mild asymmetric deep tendon reﬂex, tremor)
Hachinski ischemic score mean ± SD (range) 2.90 ± 0.6 (1–4) 9.13 ± 2.61 (5–19)
CT scans:
Normal 19 (56%) —
Mild diﬀuse atrophy AND/OR ↑ ventricles 15 (44%) —
Atrophy + leukoaraiosis — 12 (26%)
Focal abnormality — 34 (74%)
DM: Diabetes Mellitus; ∗NINDS-AIREN suggested symptoms.
Educational level was an independent predictor of pro-
gression in both AD and VaD: the higher the education, the
worse the severity of dementia. Other longitudinal studies
have shown that highly educated patients and those who
have had greater participation in prediagnostic intellectual
activities have faster cognitive decline than less educated
patients; however, these groups have similar mortality rates
[9, 10]. Surrogates of higher cognitive reserve, such as
higher educational level, higher occupational attainment,
and higher premorbid reading activity, have been associated
with faster cognitive decline in patients with dementia [29,
30]. Those individuals with greater cognitive reserve may
tolerate a greater burden of neuropathologic conditions in
AD before clinical disease expression; relatively advanced
neuropathologic disease by the time of diagnosis may result
in faster disease progression [9, 29–31]. Cognitive reserve
may also have played a role in bearing the burden of a
cerebrovascular mechanism disrupting cognitive processing
until the point at which the patient manifests cognitive
impairment. Higher education was associated with faster
decline even in a sample presenting a relatively low level of
education. In this case, a small diﬀerence in educational level
is suﬃcient to contribute to the progression of dementia.
Because developing and developed countries present distinct
educationalranges,onecouldarguethatthisdiﬀerencecould
reﬂect a generally faster severity of decline in developed
countries.
ProgressionofdiseaseseverityinADandVaDwassimilar
duringtheperiodofobservationwithoutcontrolforvascular
risk factors. At the 12-month follow-up, about 5% of the
participants had deteriorated; at 15 months, about 9%; at 20
months, 18%; at 23 months, 28%; at 24 months, 42% of the
patients had already deteriorated. On the other hand, when
controlledforvascularriskfactors,thedatashowedthatat13
months of observation 10% of AD patients had deteriorated;
at 15 months, 17%; at 12 months, 32%; at 23 months
37%; at 24 months, 84% of these patients had declined.
Among the VaD patients, only 2% of the patients declined
before month 23, and at 24 months, about 10% had already
deteriorated. The slower progression of VaD was observed
with statistical control for hypertension and educational
attainment. Despite the borderline signiﬁcance of the AD
and VaD diﬀerence, this result deserves attention. Contrary
to our previous hypothesis, we found a slower declineInternational Journal of Alzheimer’s Disease 5
Table 2: Predictive factors in Cox Proportionate Hazards Models, including diagnosis of dementia, age, educational level, sex, family history
of dementia, and CT scan ﬁndings, for the progression of dementia (worsening of severity according to CDR scale).
Variable Hazards ratio CI 95% lower–upper P-value r
Diagnosis of dementia 0.949 0.30–3.05 .939 −0.053
Age 1.049 0.96–1.15 .318 0.048
Sex 0.433 11–1.70 .230 −0.838
Educational level 1.185 1.02–1.37 .024 0.170
Family history of dementia .785
Present 0.983 0.24–4.08 .982 −0.017
Unknown 0.559 0.11–2.89 .487 −0.581
CT ﬁndings .881
Mild diﬀuse atrophy AND/OR ↑ ventricles 15831.99 0.00–6.2E+096 .929 9.670
Atrophy + leukoaraiosis 34834.69 0.00–1.4E+097 .923 10.458
Focal abnormality 16949.11 0.00–6.6E+096 .929 9.738
Diagnosis of dementia: 0 = VaD; 1 = AD.
Table 3: Predictive factors in Cox Proportionate Hazards Models, including diagnosis of dementia, age, educational level, sex, family history
of dementia, CT scan ﬁndings, and vascular risk factors, for the progression of dementia (worsening of severity according to CDR scale).
Variable Hazards ratio CI 95% lower–upper P-value r
Diagnosis of dementia 18.627 0.94–370.77 .055 2.925
Age 1.060 96–1.17 .254 0.058
Sex 0.510 0.13–1.96 .327 −0.673
Educational level 1.323 1.10–1.59 .002 0.280
Vascular risk factors .329
Hypertension 38.32 1.37–1070.3 .032 3.646
Diabetes mellitus 0.000 0.00–2.3E+101 .992 −9.928
Hypertension + diabetes mellitus 28.30 0.74 – 1082.7 .072 3.343
Family history of dementia .339
Present 0.473 0.09–2.62 .392 −0.748
Unknown 0.305 0.05–1.81 .191 −1.187
CT ﬁndings .985
Mild diﬀuse atrophy AND/OR ↑ ventricles 547201.7 0.00–8.5E+111 .919 13.213
Atrophy + leukoaraiosis 728853.1 0.00–1.1E+117 .918 13.499
Focal abnormality 392780.9 0.00 –6.1E+116 .921 12.881
Diagnosis of dementia: 0 = VaD; 1= AD.
for VaD patients. We can hypothesize that hypertension, a
stronger risk factor for the progression of dementia [19, 20,
32–34], masked the association of diagnosis (AD or VaD)
with the progression of dementia. The adjusted model for
hypertension revealed the faster decline of the AD patients.
This ﬁnding is not surprising because hypertension is the
mainriskfactorforstroke,andsometypesofstrokearemore
common causes of VaD. Therefore,the eﬀectof hypertension
is more important for the progression of VaD than for
AD, and the mathematical control with the Cox regression
analysis showed this diﬀerence. Hypertension is the major
risk factor for VaD [34] and can be considered a prognostic
factor for the progression of this disease.
Studies have previously evaluated prognostic factors
for AD [6–11, 21–24] and for vascular dementia [13–16].
However, studies comparing the risk or prognostic factors in
AD and VaD are scarce.
Hypertension is a direct risk factor for VaD [16, 18, 19,
34, 35], and other studies have suggested that hypertension
also impacts the prevalence of AD [20, 32]; however, the
eﬀect of vascular risk factors on disease progression after
established dementia remains to be elucidated. Our study
highlights the signiﬁcance of vascular risk factors, especially
hypertension, on the progression of the severity of dementia,
andtheconsequenceofthisﬁndingisimportant.Highblood
pressure in midlife is associated with a higher incidence of
both AD and VaD in later life in longitudinal studies [20, 32,
36, 37]. Chronically high blood pressure is associated with
vessel wall thickening and narrowing of the vessel lumens
in microvessels and large cerebral arteries. Rupture of the
atheromatous plaques of larger cerebral arteries can cause
complete occlusion of these arteries and infarction of the
adjacent cerebral areas [38]. The ischemia and infarction
of areas of the brain involved in memory and function6 International Journal of Alzheimer’s Disease
increase the risk of vascular dementia [35]. Furthermore,
hypoxia-induced factors derived from ischemia may poten-
tiate amyloidogenic mechanisms and the development of
AD [39]. We hypothesize that hypertension aﬀects the
progression of dementia by the same mechanisms involved
in the pathogenesis and clinical manifestation of disease.
High blood pressure is a main risk factor for white-matter
lesions, which could promote faster progression of both VaD
and AD. The atherosclerotic burden in the brain related
to hypertension could also promote more rapid decline.
Additionally, atherosclerosis and inadequate treatment of
hypertension may induce cerebral hypoperfusion, ischemia,
and hypoxia that could hasten cognitive decline. The treat-
ment of the modiﬁable risk factors, such as hypertension,
diabetes mellitus, hypercholesterolemia, and heart disease,
is a strategy for the reduction of the risk of dementia [40–
42]. Although we did not evaluate this issue, we may expect
that the treatment of these vascular risks factors has a similar
eﬀect on slowing the progression of cognitive decline in
dementia.
The strengths of the present study were the well-deﬁned
and well-evaluated vascular risk factors at entry to the study,
the statistical model of prediction, the AD and VaD grouping
sample,andtherelevanceofthemainﬁndingsfordeveloping
countries. The deﬁnition and evaluation of vascular risk
factors were designed to be comprehensive and reliable. We
did not include the previous history or incident stroke as
vascular risk factor because only VaD patients had previous
history of stroke at baseline and incident stroke was not
observed during the follow-up. The statistical model of
prediction, adjustment, and control for variables, as well as
the graphic illustrations, demonstrated very well what could
have occur if the vascular risk factors, mainly hypertension,
were actually controlled.
One limitation of the present study was that there was
no distinction of VaD subtypes. Concept and deﬁnition
of VaD are heterogeneous and the term VaD encompasses
many diﬀerent subtypes. These diﬀerences certainly have an
impact on the clinical course of the disease. The various
forms of VaD present diﬀerent clinical, neuroimaging, and
pathological features which may aﬀect the clinical course in
diverse ways. We used the NINDS/AIREN criteria to deﬁne
vascular dementia, which is the most frequently used and the
most restrictive. We also used the Hachinski Ischemic Score
(HIS) to verify that an ischemic process was associated with
VaD and to exclude ischemia in AD. Then, our results cannot
be generalized to all deﬁnitions of VaD.
6. Conclusion
This longitudinal study showed a similar severity of decline
in both AD and VaD during two years. The impact of
hypertension and education on the progression of dementia
was also demonstrated. Vascular risk factors interacted with
the diagnosis of VaD. Education was a strong predictor of
decline. Finally, the importance of the present ﬁndings is
reinforced by the information that disability has a greater
absolute (and relative) impact on healthy-life expectancy at
birth in poorer countries [43], and prevalence and rates
of increase of dementia are higher in developing than in
developed regions [1, 44]. Health public strategies to prevent
and control treatable conditions such as hypertension may
have an important impact on the burden of dementia in
developing countries.
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